InMed制药公司于3月4日确认并批准终止Baymedica商业运营的决定——SEC文件披露

美股速递
Yesterday

根据美国证券交易委员会(SEC)最新文件披露,InMed Pharmaceuticals Inc(INM)于3月4日正式确认并通过决议,将逐步终止其旗下Baymedica部门的商业运营。该决定标志着公司战略重心调整,未来资源将更集中于核心业务领域。

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Most Discussed

  1. 1
     
     
     
     
  2. 2
     
     
     
     
  3. 3
     
     
     
     
  4. 4
     
     
     
     
  5. 5
     
     
     
     
  6. 6
     
     
     
     
  7. 7
     
     
     
     
  8. 8
     
     
     
     
  9. 9
     
     
     
     
  10. 10